After reviewing the literature and searching the CGGA (http://cgga.org.cn/, accessed on 25 December 2021), we confirmed that DLGAP5 expression was correlated with advanced grade and poor survival in glioma patients (Figure 9e(Fig. 9)). The gene discussed is DLGAP5; the disease is central nervous system cancer.